Stopped: Post Market Study terminated early due to the launch and subsequent incorporation of the study into the Terumo Aortic Endovascular Registry (TiGER-001).
This is an EU sponsored trial and independent of the US trial registered under Clinicaltrials.gov ID NCT02009644. The purpose of this registry is to gather clinical data on the safety and performance of the TREO Stent-Graft in patients with infrarenal abdominal aortic aneurysms. The registry is part of TREO's EU post-market surveillance plan providing long-term systematic clinical follow-up.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Aneurysm-related mortality
Timeframe: 30 days post-procedure
Stroke (excluding transient ischemic attack)
Timeframe: 30 days post-procedure
Myocardial infarction
Timeframe: 30 days post-procedure
Renal failure
Timeframe: 30 days post-procedure
Respiratory failure
Timeframe: 30 days post-procedure
Paraplegia
Timeframe: 30 days post-procedure
Bowel ischemia
Timeframe: 30 days post-procedure
Treated aneurysm rupture
Timeframe: 30 days post-procedure